Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Goodbody Health Ltd GDBYF

Healthcare Drug Manufacturers - Specialty & Generic
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal... see more

GREY:GDBYF - Post Discussion

Goodbody Health Ltd > Sativa group
View:
Post by Accroche on Apr 21, 2020 4:25pm

Sativa group

Looks like a good acquisition to market the production of CBD with shelves products. But at what price??? Is it too expensive or faiur value?
Comment by lscfa on Apr 21, 2020 6:43pm
Paying 9x sales is too much.......
Comment by lscfa on Apr 21, 2020 6:48pm
9x sales is way too much considering not profitable any time soon.   See image. God damn STIL mgmt must be desperate,  
Comment by lscfa on Apr 21, 2020 7:06pm
Undervalues STIL at $9.7 mil. Co. has spent over $20 mil to get extraction plants operational.  $18 mil for Sativa (65%) + $9.7 mil for STIL (35%)  of merged co. = $27.7 mil.      
Comment by lscfa on Apr 21, 2020 7:27pm
Worse that MOTA deal...... lscfa (730) User Actions   February 26, 2020 - 07:27 PM 25 Reads  Post# 30738270 RE:Merger  $27 million for 132 million diluted stillcanna shares = $0.20/sh. No damn premium paid from ridiculously low current market price. WTF? lscfa wrote ...more  
Comment by Accroche on Apr 21, 2020 7:46pm
It's a letter of intend... What does it mean? They have to do due dilligence. Will they revise the price? I'm concerned with the management ability to make these kind of transaction. First Mota was way to expensive. Better this time but again, they worth more than this deal to me... 
Comment by lscfa on Apr 21, 2020 6:51pm
It's an RTO so where will it be listed - UK, CSE, or both?
Goodbody Health Ltd